Logo of Spica Therapeutics

Spica Therapeutics

Spica Therapeutics is a biotechnology company dedicated to transforming the treatment of cancer, fibrosis and inflammatory diseases through precision targeting macrophage biology. Founded on pioneering research from Aarhus University, the company utilizes a proprietary functional fingerprinting platform to identify and deplete specific pathogenic macrophage subsets while preserving beneficial immune cells. Headquartered in Antwerp, Belgium, Spica is backed by a syndicate of leading life science investors. 

Content by Spica Therapeutics

ProBioGen CLD Shake Flask Assay Performance Analysis Producer Clones
| 2 min read
Industry Perspectives
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Researcher examining a multiwell plate alongside cell culture dishes in a laboratory.
Skip RNA purification for faster RT-qPCR workflows
Explore how direct cell lysis can reduce sample preparation steps and support efficient gene expression analysis by RT-qPCR.
Webinars
Thermo Fisher Scientific
Abstract rainbow-colored beams of light spreading across a dark background.
How to choose the right fluorochromes for complex flow cytometry panels
Compare fluorochromes based on resolution, spillover, antigen expression, and other factors that can affect panel performance.
Whitepaper
BD Bio
Illustration of multiple glowing blue and purple spherical cells against a dark blue background.
Technology Guide: High-content analysis in modern drug discovery
As researchers embrace more complex cellular models, high-content analysis brings new opportunities and challenges to drug discovery.
Technology Guides
Yokogawa